Τετάρτη 24 Ιανουαρίου 2018

Benefit of therapeutic drug monitoring to disclose pharmacokinetic interaction between sunitinib and calcium channel blocker.

https:--academic.oup.com-images-oup_pubm Related Articles

Benefit of therapeutic drug monitoring to disclose pharmacokinetic interaction between sunitinib and calcium channel blocker.

Ann Oncol. 2016 08;27(8):1651-2

Authors: Da Silva F, Thomas-Schoemann A, Huillard O, Goldwasser F, Blanchet B

PMID: 27117534 [PubMed - indexed for MEDLINE]



http://ift.tt/2n6XURf

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου